Table 2.
Parameter | Time | Control | F | F2 | FG | G |
---|---|---|---|---|---|---|
Percent of weekly increment in body weight | W1 | 3.3 ± 0.26 | 4.2 ± 0.39 | 4.3 ± 0.34∗ | 4.3 ± 0.34∗ | 3.6 ± 0.31 |
W2 | 3.6 ± 0.28 | 4.4 ± 0.31∗ | 4.7 ± 0.27∗ | 4.7 ± 0.27∗ | 3.0 ± 0.34 | |
W3 | 3.7 ± 0.29 | 4.3 ± 0.33∗ | 5.1 ± 0.23 | 4.5 ± 0.26 | 3.1 ± 0.29 | |
| ||||||
Energy uptake Kcal/day/100 g (BW) |
W1 | 23 ± 1.4 | 26 ± 1.2 | 26 ± 1.2 | 26 ± 1.2 | 23 ± 1.4 |
W2 | 21 ± 1.3 | 28 ± 1.6 | 33.2 ± 1.5@ | 32.2 ± 1.4@ | 18 ± 1.1#,$ | |
W3 | 20 ± 0.9 | 27 ± 1.6 | 35.1 ± 1.9∗ | 33.9 ± 1.7∗ | 19 ± 1.2 | |
| ||||||
Energy taken from fructose Kcal/day/100 g (BW) |
W1 | 0 | 9.31 ± 0.39 | 10.18 ± 0.38 | 10.18 ± 0.38 | 0 |
W2 | 0 | 8.92 ± 0.38 | 14.64 ± 0.68‡ | 15.24 ± 0.68‡ | 0 | |
W3 | 0 | 8.78 ± 0.26 | 15.25 ± 0.54‡ | 16.15 ± 0.54‡ | 0 | |
| ||||||
Water uptake μL/min |
W1 | 15.2 ± 1 | 12.8 ± 0.6 | 12.4 ± 0.53 | 11.4 ± 0.48 | 15.3 ± 1 |
W2 | 14.3 ± 1.2 | 13.6 ± 0.8 | 13.4.4 ± 1.93 | 22.4 ± 1.32∗,‡,#, | 21.6 ± 2.95 | |
W3 | 15.4 ± 1.1 | 12.4 ± 0.65 | 11.1 ± 1.8 | 23.1 ± 1.9∗,‡,# | 24 ± 2.1∗,‡,#, | |
| ||||||
UFR μL/min/100 g (BW) |
W1 | 2.18 ± 0.2 | 1.70 ± 0.1 | 1.53 ± 0.1 | 1.44 ± 0.1∗ | — |
W2 | 2.09 ± 0.18 | 1.62 ± 0.10$ | 1.49 ± 0.12$ | 5.42 ± 0.5∗,‡,# | 4.30 ± 0.60 | |
W3 | 2.16 ± 0.12 | 1.55 ± 0.08$ | 1.43 ± 0.06∗$ | 4.95 ± 0.7∗,‡,#, | 4.06 ± 0.27∗ |
Percentage of increment of body weight was performed weakly while calories and water uptake and urine flow rate were measured in the 1st, 2nd, and 3rd weeks of gentamicin treatment which correspond to the last 3 weeks of the high fructose water treatment period. Results are expressed in mean ± SEM. ∗, ‡, #, $, and @ indicate statistical significance as compared to control, F, F2, FG, and G groups, respectively (P < 0.05).